Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Cells Reprogrammed on the Computer

Published: Monday, August 05, 2013
Last Updated: Monday, August 05, 2013
Bookmark and Share
Scientists have developed a model that makes predictions from which differentiated cells– can be very efficiently changed into completely different cell types.

This can be done entirely without stem cells. These computer-based instructions for reprogramming cells are of huge significance for regenerative medicine. The LCSB researchers present their results today in the prestigious scientific journal “Stem Cells”. This is the first paper based solely on theoretical, yet practically proven, results of computational biology to be published in this journal. (DOI: 10.1002/stem.1473)

All cells of an organism originate from embryonic stem cells, which divide and increasingly differentiate as they do so. The ensuing tissue cells remain in a stable state; a skin cell does not spontaneously change into a nerve cell or heart muscle cell. “Yet the medical profession is greatly interested in such changes, nonetheless. They could yield new options for regenerative medicine,” says Professor Antonio del Sol, head of the Computational Biology group at LCSB. The applications could be of enormous benefit: When nerve tissue becomes diseased, for example, then doctors could take healthy cells from the patient’s own skin. They could then reprogram these to develop into nerve cells. These healthy nerve cells would then be implanted into the diseased tissue or even replace it entirely. This would treat, and ideally heal, diseases such as Parkinson’s disease.

The techniques for cell programming are still in their infancy. Stem cell researchers Shinya Yamanaka and John Burdon received the Nobel Prize for converting differentiated body cells back into stem cells only last year. The first successful direct conversion of skin cells to nerve cells in the lab was in 2010. Biologists add refined cocktails of molecules, i.e. growth factors, to the cell cultures in a certain order. This allows them to control the genetic activity in the conversion process. However, this method so far has been largely guided by – educated – trial and error.

Variable jumping between different cell lines is possible

Now, the LCSB researchers have replaced trial and error with computer calculations, as computer scientist and PhD student at LCSB Isaac Crespo explains: “Our theoretical model first queries databases where vast amounts of information on gene actions and their effects are stored and then identifies the genes that maintain the stability of differentiated cells. Working from the appropriate records, the model suggests which genes in the starting cells need to be switched on and off again, and when, in order to change them into a different cell type.”

“Our predictions have proved very accurate in the lab,” says Professor del Sol: “And it turns out it makes no difference at all how similar the cells are. The models work equally well for cell lines that have only just branched off from one another as for those that are already very far apart.” Prof. del Sol’s and Crespo’s model thus allows highly variable jumping between very different cell types without taking a detour via stem cells.

The biologists and medical scientists still have their lab work cut out for them: They have to identify all the growth factors that initiate the respective genetic activities in the correct, predicted order.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Gut Model HuMiX Works Like the Real Thing
Developed by scientists at the Luxembourg Centre for Systems Biology, the “Human Microbial Cross-talk” model is representative of the actual conditions and processes that occur within our intestines.
Friday, May 13, 2016
New Clues For Early Colorectal Cancer Detection
Study identifies new biomarkers which could help detect colorectal cancer.
Monday, October 13, 2014
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
NIH Study Determines Key Differences between Allergic and Non-Allergic Dust Mite Proteins
Researchers at NIH have uncovered factors that lead to the development of dust mite allergy and assist in the design of better allergy therapies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos